Methylene Blue Liquid drops

• Improves memory, attention, and executive function by enhancing mitochondrial efficiency in neurons, increasing ATP production, and reducing oxidative stress. Early research suggests potential neuroprotective effects, possibly slowing cognitive decline in Alzheimer’s or Parkinson’s, though human studies are limited.
• Boosts cellular energy (ATP) production by optimizing mitochondrial function, potentially reducing fatigue and enhancing vitality, particularly in chronic fatigue conditions like long-COVID or autoimmune diseases.
• Acts as a redox agent to reduce oxidative stress linked to aging and chronic diseases. Preliminary studies suggest it may support skin health by protecting against oxidative damage and promoting collagen production, with investigational use for premature aging conditions like progeria.
• Exhibits antibacterial, antifungal, and antiparasitic effects, historically used for malaria and urinary tract infections. May aid chronic infections or wound healing by reducing infection rates and inflammation.
• Regulates neurotransmitters like serotonin and dopamine as a monoamine oxidase inhibitor (MAOI), potentially benefiting mood disorders or ADHD symptoms, but carries risks like serotonin syndrome when combined with certain medications.
• Reduces inflammation through anti-inflammatory properties, potentially helping conditions like long-COVID or chronic pain by inhibiting inflammatory cytokines and improving mitochondrial function.
• May improve retinal function and vision by restoring mitochondrial metabolism,

Safe doses typically range from 0.5–2 mg/kg body weight daily (e.g., 40–160 mg for an 80 kg person), starting low to monitor effects. Use pharmaceutical-grade MB to avoid contaminants. Common side effects include nausea, headache, and blue discoloration of urine or tongue. Serious risks include serotonin syndrome (with serotonergic drugs), hemolytic anemia (in G6PD deficiency), or methemoglobinemia at high doses. 

NOTE * Avoid use if pregnant, breastfeeding, taking SSRIs/SNRIs/MAOIs, or with G6PD deficiency or severe liver/kidney issues.